Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 2
1(33.3%)
3Total
N/A(2)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07199504Phase 2Recruiting

A Self-Controlled Study on the Treatment of Restless Legs Syndrome in Uremia With Dipyridamole

Role: lead

NCT07348913Completed

Impact of Regular Low-Frequency Hemoperfusion on Medium- to Long-Term Prognosis in Maintenance Dialysis Patients

Role: lead

NCT07291154Not ApplicableRecruiting

Impact of APP-assisted Patient Management on the Quality Control of Blood Purification Therapy

Role: lead

NCT06568835Not ApplicableRecruiting

The Effect of Active Exercise on Maintenance Haemodialysis Patients

Role: lead

All 4 trials loaded